Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Amlodipine and Rosuvastatin FDC vs Separate Tablets
NCT02075619Phase 1Completed
- Sponsor
- GSK
- Start
- Mar 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of amlodipine + rosuvastatin in hypertension (HTN) and hypercholesterolemia (6 arms), sponsored by GSK. Primary endpoint: Plasma pharmacokinetics parameters of amlodipine and rosuvastatin. Started Mar 2014; status: completed.
02
Drugs
amlodipine + rosuvastatin
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02075619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02075619.